Contract Development & Manufacturing Organizations (CDMOs) are crucial in driving innovation within the pharma industry. Companies are increasingly leveraging the expertise of CDMOs through technology transfers to foster innovation and accelerate the growth of new drugs.
Technology transfer is essential at various stages of drug development, from preclinical phases to commercialization. This white paper highlights the significance of CDMOs in advancing pharmaceutical development and discusses the benefits of collaboration for efficient, cost-effective and high-quality drug development processes.
Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy